The IPRO Board of Directors, Medical Review Board, Network Council, and committees support and facilitate Network operations. The roles and purpose of these groups are periodically reassessed to ensure that they continue to meet current needs. Board and committee members include representatives from dialysis and transplant facilities, as well as other strategic organizations in each Network service area.

The involvement of patient representatives is vital to the success of Network activities and to improving the quality of care and life for ESRD patients as we move toward the vision of patient-centered care; therefore, all boards and committees include at least two patient representatives.

• The Medical Review Boards for each Network is composed of renal professionals and patients qualified to evaluate the quality and appropriateness of care delivered to ESRD patients. Members of the boards represent the diverse geographic areas and the multiple professional disciplines of the Network service area including nephrologists, nurses, social workers, dietitians, technicians, and at least two ESRD patients.
• Members are elected for a three-year term, with staggered expiration dates, to accommodate rotation of new and retiring members.
• Board members meet at a minimum of two times per year. Attendance at 50 percent of meetings is mandatory to retain board status.
• Each member is required to sign a Conflict of Interest statement and Affirmation of Agreement with IPRO’s Confidentiality, Privacy, and Security Policy on an annual basis.

The Medical Review Board (MRB) serves as an expert panel that analyzes and advises the IPRO Board of Directors on quality improvement activities and policies and procedures for the ESRD Network Program.  The MRB is an advisory panel to the Network Council on the quality and appropriateness of care delivered to ESRD patients. The MRB also advises on analysis of local data such as clinical performance measures, and develops, implements, and evaluates Network quality improvement projects.